CALL for ESO Social Media Scientific Officer
The European School of Oncology is looking for an oncology professional to help with the scientific content of it’s current social media pages on Facebook and Twitter (ESOncology).
ESO has been present on social media for a while but we would like to interact more with our audience and the key to this is to have the help of someone from our audience. We are therefore looking for an oncology professional who could dedicate some time to helping us communicate “oncologist to oncologist”.
The ideal candidate is someone who regularly uses social media for their profession and therefore helping ESO wouldn’t impact too much on their available time.
The aim of this role is to use your scientific knowledge and social media expertise to represent ESO’s voice on social media and help promote its activities.
Your duties would involve:
- Helping to put together a social media policy based on ESO’s mission.
- Monitoring social media for posts by other parties that reflect ESO’s mission.
- Commenting, Liking, and reposting other parties posts using the ESO Social Media pages, and in accordance with the social media policy.
- Helping to promote ESO’s activities on social media from a scientific angle.
- Help evaluate new social media platforms for future use.
The role of Social Media Scientific Officer will last for a year, with an initial agreement for 6 months that would be renewed on evaluation.
ESO will pay 1,500 euros per semester.
- Young oncologist with interest in a variety of oncology areas.
- Good knowledge of social media tools
How to apply
If interested, please send your CV with details of your own social media handles and a letter of motivation to Corinne Hall email@example.com by 10 January 2020.
For any questions or doubts, feel free to contact Corinne.
The European School of Oncology (ESO) was founded in 1982. ESO’s mission is reflected in its motto “Learning to Care”, which emphasizes the importance of the learning process, and the goal of caring for the patient in a holistic sense, in contrast to focusing purely on treating the disease. Due to its financial independence, ESO has the rare privilege of being able to set its own priorities. It therefore pays particular attention to developing the transfer of knowledge in areas that are least supported by industry, such as surgery and in rare pathologies (including childhood tumours), and in countries and regions with limited economic resources.